Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Scientific Reports|March 22, 2024
Association of HLA-DRB1 locus with treatment response to abatacept or TNF inhibitors in patients with seropositive rheumatoid arthritisSoojin Cha, So-Young Bang, Young Bin Joo, et al.
Clinical and Experimental Rheumatology|July 28, 2016
Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 casesSeung Taek Song, Jin Ju Kim, Seung Lee, et al.
Annals of the Rheumatic Diseases|May 21, 2013
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS studyWon Park, Pawel Hrycaj, Slawomir Jeka, et al.
Arthritis and Rheumatism|May 19, 2012
Natural killer T cell deficiency in active adult-onset Still's Disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cellsSung-Ji Lee, Young-Nan Cho, Tae-Jong Kim, et al.
Arthritis Research & Therapy|April 4, 2016
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA studyDae Hyun Yoo, Artur Racewicz, Jan Brzezicki, et al.
The Journal of Rheumatology|February 20, 2007
Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockersSang-Seokg Seong, Chan-Bum Choi, Jin-Hyun Woo, et al.
Annals of the Rheumatic Diseases|May 1, 2016
Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension studyDae Hyun Yoo, Nenad Prodanovic, Janusz Jaworski, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 3, 2023
Higher Genetic Risk Loads Confer More Diverse Manifestations and Higher Risk of Lupus Nephritis in Systemic Lupus ErythematosusYoung-Chang Kwon, Eunji Ha, Hyuk-Hee Kwon, et al.
Rheumatology International|March 12, 2016
Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort studyDam Kim, Soo-Kyung Cho, Chan-Bum Choi, et al.
Molecular Biology Reports|September 18, 2010
Upregulation of interleukin-1β production by 1,25-dihydroxyvitamin D(3) in activated human macrophagesBit-Na-Ra Lee, Tae-Hwan Kim, Jae-Bum Jun, et al.
Pageof 15